In a stroke model, Manganese (III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTm4PyP), acted in a dose dependent manner in reducing cytochrome c and superoxide radical, and reducing cleaved caspase-3 formation [111]. This evidence concerns the gene CYCS and stroke disorder.